Volume 67, Issue 1, Pages (July 2017)

Slides:

Advertisements

Similar presentations

Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Access to HCV triple therapy with Telaprevir or Boceprevir in a real-life setting in HIV-HCV.

Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 67, Issue 3, Pages (September 2017)

Volume 63, Issue 1, Pages (July 2015)

Volume 53, Issue 1, Pages (July 2010)

Volume 46, Issue 3, Pages (March 2007)

Volume 56, Issue 1, Pages (January 2012)

Volume 67, Issue 3, Pages (September 2017)

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Volume 67, Issue 2, Pages (August 2017)

Volume 50, Issue 4, Pages (April 2009)

Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen? Patrick Marcellin, E. Jenny Heathcote,

Hepatitis C: the path towards effective universal therapy

Volume 42, Issue 6, Pages (June 2005)

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Volume 44, Issue 4, Pages (April 2006)

NS5A inhibitors in the treatment of hepatitis C

Volume 42, Issue 5, Pages (May 2005)

Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals Liver Cancer - DOI: / Fig. 1. Flowchart of included.

Immigration and viral hepatitis

Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis Astrid Marot, Jean Henrion, Jean-François.

Volume 66, Issue 1, Pages 1-4 (January 2017)

Ype P. de Jong, Charles M. Rice, Alexander Ploss Journal of Hepatology

Living donor liver transplantation: is the hype over?

Volume 59, Issue 4, Pages (October 2013)

Volume 44, Pages S19-S24 (January 2006)

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection Anaïs Vallet-Pichard,

Jordan J. Feld, Graham R. Foster Journal of Hepatology

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Volume 65, Issue 4, Pages (October 2016)

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 62, Issue 3, Pages (March 2015)

Acute hepatitis C: Current status and remaining challenges

Darius Moradpour, Arash Grakoui, Michael P. Manns

EASL Clinical Practice Guidelines: Wilson’s disease

Age and liver transplantation

Volume 69, Issue 6, Pages (December 2018)

Economics of chronic hepatitis B and hepatitis C

Volume 42, Issue 3, Pages (March 2005)

Volume 68, Issue 3, Pages (March 2018)

Volume 57, Issue 5, Pages (November 2012)

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Volume 70, Issue 1, Pages (January 2019)

Chetana Lim, Chady Salloum, Daniel Azoulay

Volume 67, Issue 3, Pages (September 2017)

Immigration and viral hepatitis

The potential of induced pluripotent stem cell derived hepatocytes

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

Volume 63, Issue 1, Pages (July 2015)

Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection Isabelle Chemin,

Volume 51, Issue 2, Pages (August 2009)

Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences Zobair M. Younossi, Aybike Birerdinc,

Volume 66, Issue 3, Pages (March 2017)

New trials and results in systemic treatment of HCC

Liver transplantation in children

Reply to: “Flow cytometry makes all the difference”

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Genetics of hepatocellular carcinoma: The next generation

Changing thresholds and incidence of antibiotic treatment of cystic fibrosis pulmonary exacerbations, 1995–2005 Donald R. VanDevanter, Eric P. Elkin,

Hepatitis C: the path towards effective universal therapy

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Volume 67, Issue 1, Pages 23-31 (July 2017) Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients – French ANRS CO13 HEPAVIH cohort Lionel Piroth, Linda Wittkop, Karine Lacombe, Eric Rosenthal, Camille Gilbert, Patrick Miailhes, Patrizia Carrieri, Julie Chas, Isabelle Poizot-Martin, Anne Gervais, Stéphanie Dominguez, Didier Neau, David Zucman, Eric Billaud, Philippe Morlat, Hugues Aumaitre, Caroline Lascoux-Combe, Anne Simon, Olivier Bouchaud, Elina Teicher, Firouzé Bani-Sadr, Laurent Alric, Daniel Vittecoq, François Boué, Claudine Duvivier, Marc-Antoine Valantin, Laure Esterle, François Dabis, Philippe Sogni, Dominique Salmon Journal of Hepatology Volume 67, Issue 1, Pages 23-31 (July 2017) DOI: 10.1016/j.jhep.2017.02.012 Copyright © 2017 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Frequencies of sustained virological responses 12 weeks after end of therapy (SVR12). (A) Data grouped according to prescribed DAA regimen which was evaluated in adjusted exact logistic regression analysis (see Table 2A, B). (B∗, C and D∗) Data grouped according to the selected covariables which were evaluated in adjusted exact logistic regression analysis (see Table 2A, B). ∗Patients receiving SOF+RBV have been excluded from this analysis. Vertical bars represent 95% confidence intervals calculated using the exact binomial distribution. Journal of Hepatology 2017 67, 23-31DOI: (10.1016/j.jhep.2017.02.012) Copyright © 2017 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2017 67, 23-31DOI: (10.1016/j.jhep.2017.02.012) Copyright © 2017 European Association for the Study of the Liver Terms and Conditions